Design
Review
Authors
Loading...
May guide cGMP pathway research in vasodilation; leaves open prospective trials for modern therapeutic targeting.
The guanylate cyclase-cGMP system is a crucial second-messenger pathway mediating the effects of nitrovasodilators, endothelium-dependent vasodilators, and atrial peptides.
Murad et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: